Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis

AIM: To assess the ability of signature metabolites alone, or in combination with the model for end-stage liver disease-Na (MELD-Na) score to predict mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. MATERIALS & METHODS: Plasma metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Mindikoglu, Ayse L, Coarfa, Cristian, Opekun, Antone R, Shah, Vijay H, Arab, Juan P, Lazaridis, Konstantinos N, Putluri, Nagireddy, Ambati, Chandrashekar R, Robertson, Matthew J, Devaraj, Sridevi, Jalal, Prasun K, Rana, Abbas, Goss, John A, Dowling, Thomas C, Weir, Matthew R, Seliger, Stephen L, Raufman, Jean-Pierre, Bernard, David W, Vierling, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997913/
https://www.ncbi.nlm.nih.gov/pubmed/32025330
http://dx.doi.org/10.2144/fsoa-2019-0124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997913/
https://www.ncbi.nlm.nih.gov/pubmed/32025330
http://dx.doi.org/10.2144/fsoa-2019-0124

Ejemplares similares